Two more drug-making giants will officially start selling popular commercial medications on the White House's discounted pharmaceutical site as soon as Monday, CBS News exclusively learned. American pharmaceutical companies Abbvie and Genentech become the 10th and 11th companies to provide their prescriptions at a reduced rate on the "TrumpRx" site.
Main Idea: Abbvie and Genentech will begin selling more drugs on the TrumpRx site, as the Trump administration expands its effort to lower prescription costs for uninsured patients.
Key Points:
Most patients with insurance will see little change, while uninsured people may still face high out-of-pocket costs even after the discount.
Abbvie and Genentech discounts on TrumpRx could cut prices for some uninsured patients, easing costs for medicines like Humira and Xofluza.
Rate how each entity in this article affected the American people.
Central company launching Humira on TrumpRx at a steep discount.
Central company launching Xofluza on TrumpRx as part of the article’s main development.
Mentioned as the body that has not yet taken up the proposed healthcare plan.
Comments here are the same thread shown when this article appears in The Pulse.
No comments on this article yet.
Sign in to comment